Not surprisingly, given the relationship between thyroid autoimmunity and cancer, NF-κB is also involved in thyroid carcinogenesis, and it is considered a potential pharmacological target for new therapies against the most aggressive types of thyroid cancers. This evidence concerns the gene NFKB1 and thyroid gland disorder.